Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-09-22

FDA Approved: DOXAZOSIN — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approves a supplemental application for doxazosin mesylate from Aurobindo Pharma Limited under the DOXAZOSIN ANDA, signaling regulatory approval for an addi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Doxazosin (doxazosin)

Snippet

SUPPL AP for DOXAZOSIN (DOXAZOSIN MESYLATE)